SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Emisphere -- Ignore unavailable to you. Want to Upgrade?


To: Madharry who wrote (196)11/25/2002 7:24:45 PM
From: Miljenko Zuanic  Respond to of 272
 
One or two of those trials are already completed. Potential partner(s) may ask for larger pilot study (~200 pts) before get excited about oral insulin. EMIS have sufficient cash to run one or two. The question is do they have experienced clinicians to arrange, write protocol, and oversee trials? This is where pharma comes.

Miljenko